Dermatology

Guest: J. Eugene Huffstutter, MD

Even the best rheumatologists aren’t mind readers, and it’s difficult to know that a patient is suffering if they don’t tell you. That’s why Dr. Joseph Huffstutter, Assistant Clinical Professor at University of Tennessee College of Medicine at Chattanooga, breaks down communication methods that will help you uncover psoriatic arthritis (PsA) symptoms that your patients may not be disclosing.

Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

FDA medical oncologists discuss the agency’s March 23, 2017 approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma.

Released May 22, 2017

Host: Brian P. McDonough, MD, FAAFP

Dr. Michael Stierstorfer, Clinical Associate Professor of Dermatology at the University of Pennsylvania School of Medicine and founder of East Penn Dermatology, has led efforts to teach clinicians about Type IV allergies as potential causes for common gastrointestinal diseases such as IBS, coining the term "allergic contact enteritis." He joins Dr. Brian McDonough to discuss intersections between dermatology and gastroenterology in the study of hypersensitivity reactions.

[Read the Article]

In a new study, researchers from the University of California-Los Angeles studied tumor response and overall survival following the administration of a new treatment among patients with advanced melanoma. This agent, called pembrolizumab, is an antibody that blocks PD-1, a protein which prevents the body's immune system from attacking the cancer.

The researchers tested pembrolizumab on more than 650 patients in North America, Europe and Australia. They looked at tumor response before and after treatment and found that the lesions were smaller in about one third of patients. In patients who responded to the treatment, seventy-five percent maintained the response at one or two years.

[Watch more videos of The JAMA Report]

Host: Jennifer Caudle, DO

When do you refer to dermatologists? And what are some of the common & uncommon dermatologic conditions that PCPs should refer to dermatologists? Host Dr. Jennifer Caudle welcomes Dr. Jeanine B. Downie to discuss some of the "hot topics" in dermatology and best practices in developing a good relationship between the primary care clinician and the dermatologist. Dr. Downie, director of Image Dermatology in New Jersey, is a fellow of the American Academy of Dermatology.

Host: Brian P. McDonough, MD, FAAFP

Dr. Brian McDonough welcomes Dr. John Ely, Professor of Family Medicine at the University of Iowa Carver College of Medicine. Dr. Ely has written numerous articles addressing the top questions surfacing in general practice. He joins Primary Care Today to focus on perhaps the most common question asked between colleagues in family medicine: "What is this rash?"

Host: Brian P. McDonough, MD, FAAFP

Dr. Brian McDonough welcomes Dr. Jonathan Firnhaber, Clinical Assistant Professor of Family Medicine at East Carolina University School of Medicine, to provide top recommendations for prevention, assessment, and treatment of skin cancer at the primary care level.

Host: Brian P. McDonough, MD, FAAFP

From patient consultation services to remote physician visits, telemedicine is rapidly gaining a foothold in clincial practice. But what are the potential gains vs pitfalls for integrating these technologies at the primary care level? Dr. Mark Seraly, practicing dermatologist and founder of DermatologistOnCall.com, joins Dr. Brian McDonough to discuss clinical, operational, and financial trends in telemedicine today.

Host: Brian P. McDonough, MD, FAAFP

Irritable Bowel Syndrome affects an estimated one out of ten people in the US, yet the causes for this disease are multivariate and often unknown from case to case, creating a reputation in practice as a "waste basket diagnosis." Dr. Michael Stierstorfer, Clinical Associate Professor of Dermatology at the University of Pennsylvania School of Medicine and founder of East Penn Dermatology, has been a pioneer in helping clinicians better understand one potential cause of IBS. His own experience as IBS patient led to the remarkable discovery of an allergic contact enteritits underscoring his disease, which has led to new diagnostic and treatment algorithms for IBS patients nationwide. Dr. Stierstorfer joins Dr. Brian McDonough to discuss this unexpected path toward discovery and subsequent career specialization.

Host: Prathima Setty, MD

Dr. Prathima Setty welcomes board certified dermatologist Dr. Dina Nicole Anderson to discuss the various cosmetic concerns of post menopausal patients, the effects of estrogent on the skin, how to counsel patients, treatment recommendations, and much more. Dr. Anderson is a board certified dermatologist in private practice in New York City. She was also the Director of Cosmetic Dermatology at SUNY Downstate in Brooklyn, NY. Dr. Anderson is a member of various academic medical societies including American Academy of Dermatology, the Women's Dermatologic Society, and the American Society of Cosmetic Dermatology & Aesthetic Surgery.

About NAMS

The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit